1. Ames Gross , “Regulatory Changes in Japan’s Pharmaceutical Sector,” Pacific Bridge Medical (November 1998)
2. John Abraham , “A Licence to Print Money?,” Health Matter, 43 (Winter, 2000/2001)
3. Robin F. Harman , “The EMEA – Drug Regulation at a Supranational Level,” The Pharmaceutical Journal 269(November 23, 2002): 752
4. Zachary Brennan , “Amended ICH GCP Guideline Addresses Evolution of Trials Landscape,” Regulatory Affairs Professionals Society (September 29, 2015)
5. Agnes Shanley , “Pharma Manufacturing Standards and Regulations – Taking the Plunge to Harmonize Pharmaceutical Regulations,” Pharmaceutical Manufacturing 1 (March 4, 2010)